| Christian S Fahey, MD | |
|
3045 Kate Bond Rd, Bartlett, TN 38133-4004 | |
| (901) 641-3000 | |
| (901) 373-3804 |
| Full Name | Christian S Fahey |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 28 Years |
| Location | 3045 Kate Bond Rd, Bartlett, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386639334 | NPI | - | NPPES |
| 1514469 | Medicaid | TN | |
| 00171115 | Other | TN | MEDICARE RR |
| 2093256 | Other | UNITED HEALTH | |
| 4228434 | Other | TN | BCBS OF TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD0000038414 (Tennessee) | Secondary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 038414 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Msk Group Pc | 4688574262 | 124 |
News Archive
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has dosed the first subjects in a Phase 2, placebo-controlled, dose-finding study of its ARX-04 sufentanil NanoTab product candidate.
As governments, industry and public interest groups from across the globe prepare to meet next week to discuss endocrine-disrupting chemicals and other international chemical safety issues, the Endocrine Society and IPEN released a new guide documenting the threat endocrine-disrupting chemicals (EDCs) pose to human health.
According a new study, unsatisfying drug for anxiety reveals scientists a promising novel anti-cancer drug target.
The ever-slowing capacity to clear the build-up of such toxins as isoprostanes and misfolded proteins that accumulate in the brains of Alzheimer's disease patients causes the death of cells involved in memory and language.
› Verified 7 days ago
| Entity Name | Msk Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376541409 PECOS PAC ID: 4688574262 Enrollment ID: O20040110000141 |
News Archive
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has dosed the first subjects in a Phase 2, placebo-controlled, dose-finding study of its ARX-04 sufentanil NanoTab product candidate.
As governments, industry and public interest groups from across the globe prepare to meet next week to discuss endocrine-disrupting chemicals and other international chemical safety issues, the Endocrine Society and IPEN released a new guide documenting the threat endocrine-disrupting chemicals (EDCs) pose to human health.
According a new study, unsatisfying drug for anxiety reveals scientists a promising novel anti-cancer drug target.
The ever-slowing capacity to clear the build-up of such toxins as isoprostanes and misfolded proteins that accumulate in the brains of Alzheimer's disease patients causes the death of cells involved in memory and language.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christian S Fahey, MD 6077 Primacy Pkwy Ste 140, Memphis, TN 38119-5742 Ph: (901) 725-8347 | Christian S Fahey, MD 3045 Kate Bond Rd, Bartlett, TN 38133-4004 Ph: (901) 641-3000 |
News Archive
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has dosed the first subjects in a Phase 2, placebo-controlled, dose-finding study of its ARX-04 sufentanil NanoTab product candidate.
As governments, industry and public interest groups from across the globe prepare to meet next week to discuss endocrine-disrupting chemicals and other international chemical safety issues, the Endocrine Society and IPEN released a new guide documenting the threat endocrine-disrupting chemicals (EDCs) pose to human health.
According a new study, unsatisfying drug for anxiety reveals scientists a promising novel anti-cancer drug target.
The ever-slowing capacity to clear the build-up of such toxins as isoprostanes and misfolded proteins that accumulate in the brains of Alzheimer's disease patients causes the death of cells involved in memory and language.
› Verified 7 days ago
Christopher Allen Ferguson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3045 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-381-4664 Fax: 901-373-0809 | |
Arsen H Manugian, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3045 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-641-3000 Fax: 901-373-3804 | |
Robert R Jones, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3045 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-381-4664 Fax: 901-373-3804 | |
Dr. Jean Simard, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3045 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-381-4664 Fax: 901-373-3804 | |
Christopher Mark Pokabla, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3045 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-381-4664 Fax: 901-373-4870 | |
Mark S Harriman, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3045 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-381-4664 Fax: 901-373-0809 |